1. Name and Address of Reporting Person * |
Â
Kariv Tomer |
|
2. Date of Event Requiring Statement (Month/Day/Year) 01/25/2013 |
3. Issuer Name and Ticker or Trading Symbol Arno Therapeutics, Inc [ARNI]
|
C/O ARNO THERAPEUTICS, INC., 200 ROUTE 31 NORTH, SUITE 104 |
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
__X__ Director |
_____ 10% Owner |
_____ Officer (give title below) |
_____ Other (specify below) |
|
|
5. If Amendment, Date Original Filed(Month/Day/Year)
|
FLEMINGTON, NJ 08822 |
6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
|
Table I - Non-Derivative Securities Beneficially Owned |
|
1.Title of Security (Instr. 4) |
2. Amount of Securities Beneficially Owned (Instr. 4) |
3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) |
4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock
|
1,497,248
|
I
|
By Pontifax (Cayman) II L.P.
(1)
|
Common Stock
|
1,127,820
|
I
|
By Pontifax (Israel) II L.P.
(1)
|
Common Stock
|
437,807
|
I
|
By Pontifax (Israel) II - Individual Investors L.P.
(1)
|
|
1. Title of Derivative Security (Instr. 4) |
2. Date Exercisable and Expiration Date (Month/Day/Year) |
3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) |
4. Conversion or Exercise Price of Derivative Security |
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) |
6. Nature of Indirect Beneficial Ownership (Instr. 5) |
Date Exercisable |
Expiration Date |
Title |
Amount or Number of Shares |
Stock Option (right to buy)
|
Â
(2)
|
11/05/2020 |
Common Stock
|
30,000
|
$
1
|
D
|
Â
|
Class A Warrants (right to buy)
|
09/09/2010 |
03/09/2013 |
Common Stock
|
117,321
|
$
0.5268
|
I
|
Pontifax (Cayman) II L.P.
(1)
|
Class B Warrants (right to buy)
|
09/09/2010 |
09/09/2015 |
Common Stock
|
615,935
|
$
0.5649
|
I
|
Pontifax (Cayman) II L.P.
(1)
|
8% Senior Convertible Debentures
|
12/18/2012 |
12/18/2015 |
Common Stock
|
1,629,457
|
$
0.3
|
I
|
Pontifax (Cayman) II L.P.
(1)
|
Series A Warrants (right to buy)
|
12/18/2012 |
12/18/2017 |
Common Stock
|
1,629,457
|
$
0.5
|
I
|
Pontifax (Cayman) II L.P.
(1)
|
Series B Warrants (right to buy)
|
12/18/2012 |
06/18/2014 |
Common Stock
|
1,629,457
|
$
0.3
|
I
|
Pontifax (Cayman) II L.P.
(1)
|
Class A Warrants (right to buy)
|
09/09/2010 |
03/09/2013 |
Common Stock
|
88,373
|
$
0.5268
|
I
|
Pontifax (Israel) II L.P.
(1)
|
Class B Warrants
|
09/09/2010 |
09/09/2015 |
Common Stock
|
463,961
|
$
0.5649
|
I
|
Pontifax (Israel) II L.P.
(1)
|
8% Senior Convertible Debentures
|
12/18/2012 |
12/18/2015 |
Common Stock
|
1,227,410
|
$
0.3
|
I
|
Pontifax (Israel) II L.P.
(1)
|
Series A Warrants (right to buy)
|
12/18/2012 |
12/18/2017 |
Common Stock
|
1,227,410
|
$
0.5
|
I
|
Pontifax (Israel) II L.P.
(1)
|
Series B Warrants (right to buy)
|
12/18/2012 |
06/18/2014 |
Common Stock
|
1,227,410
|
$
0.3
|
I
|
Pontifax (Israel) II L.P.
(1)
|
Class A Warrants (right to buy)
|
09/09/2010 |
03/09/2013 |
Common Stock
|
34,306
|
$
0.5268
|
I
|
Pontifax (Israel) II - Individual Investors L.P.
(1)
|
Class B Warrants (right to buy)
|
09/09/2010 |
09/09/2015 |
Common Stock
|
180,104
|
$
0.5649
|
I
|
Pontifax (Israel) II - Individual Investors L.P.
(1)
|
8% Senior Convertible Debentures
|
12/18/2012 |
12/18/2015 |
Common Stock
|
476,467
|
$
0.3
|
I
|
Pontifax (Israel) II - Individual Investors L.P.
(1)
|
Series A Warrants (right to buy)
|
12/18/2012 |
12/18/2017 |
Common Stock
|
476,467
|
$
0.5
|
I
|
Pontifax (Israel) II - Individual Investors L.P.
(1)
|
Series B Warrants (right to buy)
|
12/18/2012 |
06/18/2014 |
Common Stock
|
476,467
|
$
0.3
|
I
|
Pontifax (Israel) II - Individual Investors L.P.
(1)
|